Platelet activation status decreases after menopause

References

• Ware JA, Coller BS. Platelet morphology, biochemistry and function. In: Willians J, editor. Hematology. 5th ed. New York: McGraw-Hill; 1995. pp 1161–201.
   Google Scholar
• Thomas DP. Pathogenesis of venous thrombosis. In: Colman RW, editor. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott; 1982. pp 820–30.
   Google Scholar
• Fuster V. Mechanisms of arterial thrombosis: foundation for therapy. Am Heart J 1998;135(Suppl):S361–6.
   Google Scholar
• Roberts HR. New concepts of blood coagulation. Haemophi-lia 1998;4:331–4.
   PubMedGoogle Scholar
• Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med 1993;328:628–35.
   PubMed Web of Science ®Google Scholar
• Andrews RK. Adhesion-dependent signalling and the initia-tion of haemostasis and thrombosis. Histol Histopathol 1998;13:837–44.
   PubMed Web of Science ®Google Scholar
• Introna M, Mantovani A. Early activation signals in endothe-lial cells. Arterioscler Thromb Vasc Biol 1997;17:423–8.
   PubMedGoogle Scholar
• Clemetson KJ, Clemetson JM. Integrins and cardiovascular disease. Cell Mol Life Sci 1998;54:502–13.
   PubMed Web of Science ®Google Scholar
• OPAS/OMS. Indicadores demográficos seleccionados por subregion de las Américas, para 1980 y 2000 [Internet]. [Washington, DC]: Organización Panamericana de la Salud; 2001 Nov. Available: http://www.paho.org/.
   Google Scholar
• FUNASA. Mortalidade proporcional por grupo de causa [Internet]. Location: FUNASA; 2001 Nov. Available: http:// www.funasa.gov.br/sis
   Google Scholar
• Nanette KW. Coronary heart disease in postmenopausal women: what we know and what we must learn. In: Crosignani PG, Paoletti R, Sarrel PM, Wenger NK, Meschia M, Soma M, editors. Women's health in menopause. Netherlands: Kluwer Academic and Fondazione Giovanni Lorenzini; 1994. pp 7–17.
   Google Scholar
• Sheifer SE, Escarce jj, Schulman KA. Race and sex differences in the management of coronary artery disease. Am Heart J 2000;139:848–57.
   Google Scholar
• Capewell S, MacIntyre K, Stewart S. Age, sex and social trends in out-of hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study. Lancet 2001;358: 1213–17.
   Google Scholar
• Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020:global burden of disease study. Lancet 1997;349:1498–504.
   PubMed Web of Science ®Google Scholar
• Perlman J, Wolff P, Finucane F, Madans J. Menopause and the epidemiology of cardiovascular disease in women. Prog Clin Biol Res 1989;320:283–312.
   PubMedGoogle Scholar
• Wuest JH, Dry TJ, Edwards JE. The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circu-lation 1953;7:801–8.
   Google Scholar
• Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;352:1196–204.
   Google Scholar
• Stevenson JC. Effects of HRT on metabolic risk factors for cardiovascular disease. In: Crosignani PG, Paoletti R, Sarrel PM, Wenger NK, Meschia M, Soma M, editors. Women's health in menopause. Netherlands: Kluwer Academic and Fondazione Giovanni Lorenzini; 1994. pp 19–26.
   Google Scholar
• Gebara OCE. Efeitos da terapia de reposição hormonal sobre a coagulação, o potencial f fibrinolitico e a Lp(a) [tese (doutorado em cardiologia)]. Sao Paulo: Faculdade de Medicina da Universidade de Sao Paulo; 1996.95 p.
   Google Scholar
• Punnonen RH, Jokela HA, Dastidar PS. Combined oestro-gen-progestin replacement therapy prevents atherosclerosis in postmenopausal women. Maturitas 1995;21:179–87.
   Google Scholar
• Lima SMRR. Efeitos do 17# estradiol sublingual sobre a vasodilatação endotélio dependente e independente em mulheres normo e hipertensas após a menopausa [tese (doutorado)]. &do Paulo: Faculdade de Medicina da Uni-versidade de Sao Paulo; 2002.109 p.
   Google Scholar
• Sarrel PM. Vasoactive effects of estrogens. In: Crosignani PG, Paoletti R, Sarrel PM, Wenger NK, Meschia M, Soma M, editors. Women's health in menopause. Netherlands: Kluwer Academic and Fondazione Giovanni Lorenzini; 1994. pp 149–57.
   Google Scholar
• McCrohon JA, Adams MR, McCredie RJ, Robinson J, Piket A, Abbey M, Keech AC, Calermajer DS. Hormone replace-ment therapy is associated with improved arterial physiology in healthy post-menopausal women. Chin Endocrinol (Oxf) 1996;45:435–41.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Mazzanti L, Cugini AM, Cester N, Garzetti GG, Romanini C. Transdermal estradiol and medroxypro-gesterone acetate in hormone replacement therapy are both antioxidants. Gynecol. Endocrinol 1995;9:137–41.
   PubMed Web of Science ®Google Scholar
• Nasr A, Breckwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 1998;12:43–59.
   PubMed Web of Science ®Google Scholar
• Miller VM, Lewis DA, Barber DA. Gender differences and endothelium- and platelet- derived factors in the coronary circulation. Chin Exp Pharmacol Physiol 1999;26:132–6.
   Google Scholar
• Nakano Y, Oshima T, Matsuura H, Kajiyama G, Kambe M. Effect of 17#-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler Thromb Vasc Biol 1998;18: 961–7.
   Google Scholar
• Spence JD. Advances in atherosclerosis. Baillieres Chin Neurol 1995;4:191–205.
   PubMedGoogle Scholar
• Russel R. Atherosclerosis - an inflammatory disease. N Engl J Med 19999;340: 115–26.
   Google Scholar
• Collins P, Beale CM. Hormone replacement and cardiovas-cular risk. In: The cardioprotective role of HRT: a clinical update. London: Parthenon Publishing; 1996. pp 12–17.
   Google Scholar
• Durán MG, Gálvez GG, de Frutos T, Diaz Recaséns J, Casado S, Lopez Farré A. 17 Beta-estradiol-stimulated nitric oxide production by neutrophils: effect on platelet activation. Obstet Gynecol 2000;95:284–90.
   PubMed Web of Science ®Google Scholar
• Liang Y, Teede H, Shiel LM, Thomas A, Craven R, Sachithanandan N, McNeil JJ, Cameron JC, Dart A, McGrath BP. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Chin Exp Pharmacol Physiol 1997;24:457–9.
   PubMed Web of Science ®Google Scholar
• Koh KK, Bui MN, Mincemoyer R, Cannon RO. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women. Am J Cardiol 1997;80:1505–7.
   PubMed Web of Science ®Google Scholar
• Lau TK, Chung T, Haines CJ. A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmenopausal women. Maturitas 1997;26:53–6.
   Google Scholar
• Aldrighi JM. Repercussoes dos estrogénios e progestogénios sobre as leseies ateroscleróticas da aorta e artérias coronarianas em coelhas ooforectomizadas submetidas a dieta hipercoles-terolémica. Ilaçoes para a clinica e para a saude publica [tese (livre docéncia em saude publica)]. SA° Paulo: Departamento de Saude Materno Infantil, Faculdade de Sailde Publica da Universidade de &do Paulo; 1996.100 p.
   Google Scholar
• Ueb C. Efeitos do raloxifeno, tamoxifeno e estrogénio sobre a aterosclerose de coelhas ooforectomizadas e hipercolesterolé-micas [tese (doutorado em cardiologia)]. Sao Paulo: Faculdade de Medicina da Universidade de &do Paulo; 2002.102 p.
   Google Scholar
• Nealen ML, Vijayan KV, Bolton E, Bray PF. Human platelets contain a glycosylated estrogen receptor #. Circ Res 2001;88:438–42.
   PubMed Web of Science ®Google Scholar
• Khetawat G, Faraday N, Nealen ML, Vijayan V, Bolton E, Noga SJ, Bray PF. Human megakaryocytes and platelets contain the estrogen receptor # and androgen receptor (AR): testosterone regulates AR expression. Blood 2000;95:2289–96.
   Google Scholar
• Hagberg IA, Lyberg T. Blood platelet activation evaluated by flow cytometry: optimized methods for clinical studies. Platelets 2000;11:137–50.
   PubMed Web of Science ®Google Scholar
• Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;97:4925–36.
   Google Scholar
• Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric char-acterisation of platelet function. Thromb Haemost 1998;79:885–96.
   PubMed Web of Science ®Google Scholar
• McCoy JP Jr. Basic principles in clinical flow cytometry. In: Keren DF, Hanson CA, Hurtubise PE, editors. Flow cytometry and clinical diagnosis. Chicago: American Society of Clinical Pathologists; 1994. pp 26–55.
   Google Scholar
• Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent mono-clonal antibodies and flow cytometry. Blood 1987;70:307–15.
   Google Scholar
• Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001;86:214–21.
   Google Scholar
• Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and /3-thromboglobulin release. Trans-fusion 1993;33:25–9.
   PubMedGoogle Scholar
• Stohlawetz P, Hergovich N, Stiegler G, Eichler HG, Hocker P, Kapiotis S, Pima B. Differential induction of P-selectin expression on platelets by two cell separators during platelet-pheresis and the effect of gender on the release of soluble P-selectin. Transfusion 1998;38:24–30.
   Google Scholar
• Dunlop LC, Skinner PM, Benda11 Lj, Favaloro EJ, Castaldi PA, Gorman JJ, Gamble JR, Vadas MA, Berndt MC. Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992;175: 1147–50.
   Google Scholar
• Shankey TV. Analysis of platelet activation using multi-parameter flow cytometry: biology and potential clinical application. Thromb Haemost 1991;65:467–76.
   PubMedGoogle Scholar
• George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. J Chin Invest 1986;78:340–8.
   Google Scholar
• Michelson AD, Barnard MR, Krueger LA, Frelinger AL, Furman MI. Evaluation of platelet function by flow cytometry. Methods 2000;21:259–70.
   Google Scholar
• Leytin V, Mody M, Semple JW, Garvey B, Freedman J. Quantification of platelet activation status by analyzing P-selectin expression. Biochem Biophys Res Commun 2000;273:565–70.
   PubMedGoogle Scholar
• Stevens RF, Alexander MK. A sex difference in the platelet count. Br J Haematol 1977;37:295–300.
   PubMed Web of Science ®Google Scholar
• Notelovitz M, Greig HB. The effect of natural oestrogens on coagulation. S Aft Med J 1975;25:101–5.
   Google Scholar
• Andersen LF, Gram J, Skouby SO, Jespersen J. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors. Am J Obstet Gynecol 1999;80:283–9.
   Google Scholar
• Pima B, Hildebrandt J, Kapiotis S. Effects of estradiol on circulating P-selectin. J Chin Endocinology and Metabolism 1996;81 (6):2350–55.
   Google Scholar
• Palabrica T, Lobb T, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848–51.
   PubMed Web of Science ®Google Scholar
• Martignoni E, Blandini F, Melzi GV, Andrea G, Sances G, Costa A, Nappi G. The influence of gender in the evaluation of platelet and plasma catecholamines. Life Sci 1993;52:1995–2004.
   Google Scholar